Work

Toxicities and outcomes: Do steroids matter?

Year: 2018

Type: article

Abstract: Immunotherapy outcomes appear to be improved in patients who have toxicities, although it is not clear whether steroids modulate the antitumor response in these patients. The links between steroid administration and doses and the toxicities from immune therapy as well as patient outcomes are discussed.

Source: Cancer

DOI: 10.1002/cncr.31627

Author: Douglas B. Johnson

Institutions: Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute, National Cancer Institute, NIH Clinical Center